Financial Shenanigans

Forensic Verdict

The reported numbers look like a faithful representation of FY2025 economic reality, not a stretched one. Operating cash flow ($319M) exceeds GAAP net income ($219M) without help from a working-capital lifeline, accruals are negative, and receivables grew almost exactly in line with revenue. The accounting concerns that exist — customer-warrant contra-revenue, a previously identified material weakness, a near-zero GAAP tax rate, and persistent post-IPO dilution — are real but disclosed, structural, and point in the same direction (a young public company growing into its controls and incentives). Watch, not Elevated.

Top two concerns. First, the Amazon warrant agreement (3.3M warrant shares vesting against up to $6.5B of future hyperscaler purchases) introduces a multi-year, non-cash contra-revenue charge that management has guided to roughly 200 bps of quarterly gross-margin drag starting Q2 FY2026. The accounting is standard for warrants-as-consideration, but it effectively hands a customer equity worth (at recent prices) more than $1B in exchange for a purchase commitment — a quiet form of revenue subsidy that will compress reported growth rates and gross margins for years. Second, the company previously identified material weaknesses in IT general controls and segregation of duties (disclosed in its FY2024 10-K). These are reported as remediated in the FY2025 10-K, but a new ERP rollout is in flight and foreign subsidiaries are explicitly carved out of full SOX testing — so the controls story is not yet "settled and tested under audit attestation across the whole perimeter."

Cleanest offsetting evidence. Working capital was a $52M headwind to FY2025 operating cash flow, not a lifeline. Receivables grew 114% against revenue growth of 115%, days-sales-outstanding held flat near 36 days, and inventory days fell from 168 to 104 — every balance-sheet test pointed the opposite direction from cash-flow inflation. PwC has been auditor since 2021 with no qualifications, restatement history, late filings, or short-seller report on file. No related-party transactions are disclosed.

One data point that would change the grade. A subsequent material-weakness or significant-deficiency finding under the first full SOX 404(b) attestation (FY2025 is ALAB's first as a large accelerated filer subject to auditor attestation) would lift the grade toward Elevated. A clean attestation, combined with a quarter or two where the warrant amortization comes in within management's guided 200 bp range, takes it lower.

The 13-Category Scorecard

Only one red and a single yellow are unambiguously material: the prior material-weakness disclosure (KM2) and the non-GAAP gap (KM1). Six categories test clean, five are yellow but disclosed and quantified, and one (EM3) is mostly mechanical — taxes and interest income will normalize as the DTA valuation allowance is consumed and as the $1.2B cash pile is redeployed.

Earnings vs Cash: The Statements Agree

Through FY2024, ALAB's CFO/NI ratio was negative because of IPO-vesting SBC that suppressed GAAP net income. For FY2025 the ratio prints at 1.46x without working-capital help, and the accrual ratio is comfortably negative.

FY2025 CFO of $319M sits cleanly on top of net income plus the SBC add-back, with working capital subtracting $52M rather than helping. There is no payables stretch or receivables sale propping up the cash-flow line. DPO actually fell from 105 days in FY2024 to 75 days in FY2025 — the company is paying suppliers faster, a hard signal to fake. The Hostile Read: SBC alone is doing most of the heavy lifting in the CFO/NI gap. The Friendly Read: this is what high-quality cash conversion looks like at a young, high-growth, fabless semiconductor.

Receivables and Revenue Move Together

The FY2024 step-up in receivables is the IPO-year balance-sheet first reset rather than channel stuffing — ALAB went from a pre-IPO data set with only one consolidated annual snapshot to a fully audited public balance sheet. The FY2025 reading is the diagnostic one: receivables grew 114.4% against revenue growth of 115.1%, a gap of less than 1 percentage point. DSO held essentially flat at 35.6 days. No evidence of stuffing the channel, extending terms, or pulling revenue forward.

Working Capital is a Headwind, Not a Lifeline

Every major working-capital line moved against cash flow. AR up $44M (timing of customer payments), prepaid expenses up $21M (R&D vendor prepayment plus a tax receivable for excess equity-comp benefits), and AP down meaningfully on a relative basis (DPO falling 30 days). Only inventory was a small positive contributor. Net result is a $52M drag — meaning the $319M CFO would be ~16% higher if working capital had merely held neutral. This is the strongest single piece of clean evidence in the forensic file. Aggressive companies pad CFO with working-capital lifelines; ALAB is doing the opposite.

The Non-GAAP Gap: Recurring SBC Wears a "Non-Recurring" Costume

FY2025 non-GAAP net income is $331M against GAAP of $219M — a 51% gap. The honest part: ALAB no longer adds back the giant IPO-vesting SBC tranche; that line is $0 in FY2025 versus $89M in FY2024. The not-so-honest part: $160M of recurring SBC is treated as if non-economic, and the income-tax adjustment ($49M) re-grosses up earnings by treating non-GAAP as if the company never had a valuation allowance ("we no longer maintain valuation allowance for non-GAAP purposes due to our profitability on a non-GAAP basis"). Two PMs reading these reconciliations will draw two different inferences:

Aggressive reading: Non-GAAP NI of $331M is the company's preferred earnings number. Strip out the discretionary income-tax true-up and the recurring SBC and the underlying number is closer to $171M, well below GAAP.

Conservative reading: The reconciliation is fully detailed, the SBC addback is industry-standard practice in semis software, and the GAAP number — at $219M, with cash to match — is the harder, lower, and more defensible figure.

Either way, the headline non-GAAP figure overstates sustainable earning power; the dilution from that SBC has to be paid back to shareholders out of future earnings.

SBC, Dilution, and Insider Selling

Diluted share count exceeds basic by 13.1 million shares in FY2025 — the in-the-money portion of unvested RSUs, PSUs, ESPP, and warrants. At a recent share price near $360, that 13 million share overhang is worth roughly $4.7 billion of future dilution to be paid out of operating cash flow. Management guidance for Q2 FY2026 already calls for 184 million diluted shares (versus 181 million in Q1 FY2026), implying continued ~1.6% per-quarter dilution from RSU vesting and the Amazon warrant.

Insider activity over the past 30 days reinforces the cost of that overhang. CEO Jitendra Mohan and President/COO Sanjay Gajendra both executed sizable 10b5-1 sales in mid-May 2026 — Mohan unloading roughly $25M of stock from a direct holding and Gajendra cumulatively selling more than $100M across multiple personal and trust accounts in two tranches. These are programmed sales, but the pattern is one-way: founder selling, no insider buying.

Customer and Supplier Concentration

These are operating and credit risks rather than accounting shenanigans — but they raise the stakes on every accounting judgment because a one-customer reset would cascade through receivables, inventory reserves, warrant-vesting probability, and the going-concern assumption embedded in the deferred-tax-asset valuation allowance. The "what would disprove it" disclosure to track is whether ALAB ever discloses two greater-than-10% customers rather than the current single-name concentration.

The Material-Weakness History and Audit Quality

The FY2024 10-K identified material weaknesses in IT general controls and segregation of duties. The aggregated effect was a "reasonable possibility that a material misstatement… would not be prevented or detected" — though they explicitly stated the deficiencies "did not result in a material misstatement to our consolidated financial statements." The FY2025 10-K reports these as remediated, but the language is forward-loaded:

"We have remediated previously identified material weaknesses… we cannot assure you that additional material weaknesses will not arise in the future, particularly as we continue to scale our operations, integrate new systems and processes such as a new enterprise resource planning system, and as certain of our foreign subsidiaries, which historically have not been subject to full SOX-based testing due to their size and scope, grow."

Auditor is PricewaterhouseCoopers LLP since 2021. Tenure is short, fees are pre-approved, the audit committee meets at least quarterly, and two of three audit committee members are designated financial experts. No qualification, late filing, restatement, change of auditor, or short-seller report appears in the public record.

The Amazon Warrant: Accounting-Correct, Economically Expensive

In Q4 FY2025, ALAB disclosed (via 8-K and the FY2025 10-K) a warrant agreement under which Amazon may purchase up to 3.3 million shares of ALAB common stock as Amazon achieves specified cumulative-purchase tranches totaling up to $6.5 billion of Smart Fabric Switches, signal conditioning products, and optical engine solutions, exercisable through 2033. As revenue is recognized against the milestones, ALAB recognizes the grant-date fair value of the corresponding warrant shares as a reduction of revenue (contra-revenue), in proportion to expected cumulative volume.

Management has guided to roughly 200 basis points of quarterly non-cash gross-margin drag starting in Q2 FY2026 from this single agreement. Treatment is conservative and disclosure is full. The economic substance is that ALAB is paying its largest customer in equity in exchange for a multi-year purchase commitment — a structure that supports growth, ties Amazon to ALAB's roadmap, and dilutes minority shareholders while reducing reported revenue and gross margins. The forensic concern is not deception; it is that bullish models built on reported gross margins of 75-76% need to be deflated to a structural 72-74% range for the warrant amortization, and that consensus growth optics will be persistently understated relative to underlying shipment volume because the contra-revenue is calibrated to revenue achieved.

Tax Quality: The Negative GAAP Rate Will Reverse

The FY2025 GAAP tax line records a $1.0M benefit on $218.2M of pretax income — a -0.4% rate. Drivers are stock-based compensation tax deductions (excess tax benefits from RSU vesting) and the foreign-derived intangible income (FDII) deduction, with the residual benefit coming from valuation-allowance dynamics ("We maintain a full valuation allowance on our federal and state deferred tax assets"). Management's own non-GAAP tax rate of 12.7% is the more useful proxy for run-rate, and management is now guiding forward non-GAAP rates in the 11-12% range. The valuation allowance will be unwound as sustainable profits emerge, and the SBC excess-benefit windfall will normalize once cumulative deductions deplete the pool. Whatever GAAP earnings investors price off in FY2025, they should haircut by 10-15% to capture the eventual normalized cash-tax expense.

Breeding Ground: Moderate

Two founders, Jitendra Mohan (CEO) and Sanjay Gajendra (President/COO), are both directors with large legacy equity stakes (Mohan's pre-IPO RSU grant: 9.5M shares; Gajendra: 9.25M shares). The remaining six directors are independent. The audit committee is independent and competent (Jack Lazar chairs, two financial experts on the three-person committee). Compensation is heavily equity-weighted but neither the CEO nor COO received new equity in FY2025 because their pre-IPO grants were still vesting — a discipline most newly public companies do not show. A clawback policy is in force. PwC has audited since 2021 with no qualifications. The breeding-ground risk is moderate and stable.

The structural feature that drives most of the residual concern is the expectation-management environment: ALAB trades at roughly 100x trailing free cash flow and well over 30x sales, has beaten consensus in every quarter since IPO, has a single customer driving 70%+ of revenue, and pays its co-founder executives largely in stock whose long-term value depends on continuing to beat. That pattern statistically correlates with accounting strain over multi-year periods. Today the numbers do not show that strain; the watchlist below is designed to catch it early.

What to Underwrite Next

Q2 FY2026 gross margin and warrant amortization. Management guided Q2 non-GAAP gross margin to ~73% (down from 76.4% in Q1 FY2026), with 200 bps attributable to the Amazon warrant. If the reported number lands at or below 73% with disclosed warrant impact materially above 200 bps, Amazon is ramping orders faster than expected — supportive on volume but a structural drag on reported margin trajectory.

First SOX 404(b) auditor attestation. The FY2025 10-K is ALAB's first year of full auditor attestation on internal controls. A clean PwC attestation downgrades the controls flag from yellow to green. An exception, particularly tied to the new ERP or to foreign subs, upgrades the forensic grade to Elevated immediately.

Customer concentration disclosure. Track whether the FY2026 10-K discloses a second greater-than-10% customer. Diversification from one to two named customers materially de-risks the revenue base and shrinks the magnitude of the contra-revenue overhang from any single warrant agreement.

Tax rate normalization. Watch the GAAP effective rate move from -0.4% in FY2025 toward the 12% non-GAAP guide. The rate of convergence will tell you how quickly the SBC excess-benefit cushion is being consumed.

Working-capital direction. If FY2026 CFO/NI stays above 1.2x without a working-capital lift (i.e., AR continues to track revenue and DPO does not stretch), the cash-flow quality argument is locked in.

The accounting risk in ALAB is a position-sizing limiter, not a thesis breaker. Reported FY2025 numbers appear to faithfully represent economics. The yellow flags — non-GAAP gap, recurring SBC dilution, near-zero GAAP tax rate, single-customer concentration, and a warrant agreement that compresses headline margins — are real, persistent, and known. They argue for a valuation haircut and a smaller initial position than a comparable name with two material customers and clean attestation history would warrant, but they do not, on the current evidence, undermine underlying earnings power.